- NBIM CEO says Nvidia still holds investment value
- The euro rises against the pound as progress in US-Iran diplomacy drags down oil prices
- Q2 Metals study puts Cisco lithium project's after-tax NPV at CAD 13.49 billion
- SHIB Price Tests Support While Burns Tick 49% Higher
- Shurgard to Report Third-Quarter Results
- Corbus Pharmaceuticals 3Q Loss/Shr $1.81 >CRBP
- PMV Pharmaceuticals 3Q Loss $34.4M >PMVP
- Gilat forecasts 2026 revenue of US$455 million to US$475 million
- Amper Issues 86,215,093 New Shares in Capital Increases
- Amper Issues 7,443,354 Shares Following Warrant Exercises
- Amper's Total Issued Shares Reach 2,276,124,087 After Capital Increase
- Amper Amends Bylaws to Reflect Share Capital of EUR 74.83 Million
- Amper Issues EUR 44 Million in Shares for 28.39% Stake in Next Gen Critical Comms
- Amper Completes 1-for-25 Share Consolidation
- POLLARD BANKNOTE LTD : ATB CORMARK CAPITAL MARKETS CUTS TO SECTOR PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO C$18 FROM C$31
- Iberdrola plans to double Spanish grid investment to €6 billion in 2027-2030
- Technos 3Q26 gross profit rises 18% year-on-year to R$ 69.7 million
- BUZZ-Top of the Street: SOBI, Sonova, BAT, Imperial Brands
- BactiQuant Reissues Q3 Trading Statement to Include Missing Report Attachment
- Southeast Asian e-commerce giant Sea (SE.US) misses Q3 earnings expectations as increased investment in AI and cloud businesses weighs on profit margin
- MasterCraft Q1 2026 transition-period net income more than triples to $12.1 million
- Diamondback Energy, KKR to Acquire Deep Blue Midland Basin
- Zimbabwe’s gold purchases in October increased by 33% year-on-year
- Spot platinum breaks through the $1,550/oz mark
- BRIEF-Finning Q3 EPS CAD 1.2
- Top Wealth Regains Compliance With Nasdaq Minimum Bid Price Requirement
- Curaleaf Secures All Required Competition Clearances for Aurora Cannabis Acquisition
- Finning Q3 2026 net income from continuing operations rises year over year to CAD 155 million; Q3 2026 revenue climbs 7% to CAD 3.04 billion
- Zcash Developer Proposes 8 MB Blocks in NU8 as Shielded Usage Grows
- Finning 3Q EPS C$1.20 >FTT.T
- Curaleaf Receives All Required Competition Law Clearances For Proposed Acquisition Of Aurora Cannabis >CURA.T
- BactiQuant Nine-Month Revenue Rises 36%
- Finning 3Q Rev C$3.04B >FTT.T
- Finning 3Q Adj EPS C$1.20 >FTT.T
- CRH Director Richard H. Fearon Reports Acquisition of $569,700 in Common Shares
- VivoPower Reschedules Strategic Update and Results Call
- Buenaventura Expects 2026 Investments of US$450-500 Million
- Dexxos Participações Buys Back 42,300 Shares
- Silver Lake prices offering of 15,000,000 First Advantage shares at $21.80 each
- XRP Ledger to introduce quantum-resistant accounts with no extra fees
- UK one-year fixed savings rates rise to 4.46% in October, Clear Score analysis shows
- Tenet Fintech Publishes Update to Financial Calendar
- QUALYS, INC. <QLYS.O>: WEDBUSH RAISES TARGET PRICE TO $185 FROM $175
- Aumovio Board Member Dr. Boris Mergell Buys EUR 99,772.90 in Shares
- ZURA BIO LTD <ZURA.O>: WEDBUSH CUTS TARGET PRICE TO $10 FROM $22
- Leverage Shares issues USD 19.5 million in exchange-traded notes
- Veradermics on Track to Deliver Topline Data From Phase 2/3 Study '306' Evaluating VDPHL01 in Female Pattern Hair Loss in 1H27 >MANE
- Exagen Backs 2026 Rev $72M-$75M >XGN
- LCI Industries: $104.50 Per Shr in Cash Bid Not a Superior Proposal >LCII
- Kalaris Therapeutics: Potential Initiation of a Phase 3 Program Now Expected in 2028, Resulting in Extension of Anticipated Cash Runway Into 2028 and Beyond Preliminary Phase 1b/2 Data Readout >KLRS
- LCI: Monomoy Cap's Revised, Unsolicited, Non-Binding Proposal Doesn't Constitute Superior Proposal >MNMY.XX LCII
- Ambiq Micro 3Q Adj Loss/Shr 5c >AMBQ
- Kalaris Therapeutics: Preliminary Data From Ongoing Phase 1b/2 Study of TH103 in nAMD Now Expected 2H 2027 >KLRS
- Ambiq Micro Sees 4Q Sales $43.5M-$44.5M >AMBQ
- Ambiq Micro Sees 4Q Adj Loss/Shr 3c-Adj Loss/Shr 9c >AMBQ
- MasterCraft Boat Holdings 4Q EPS 50c >MCFT
- MasterCraft Boat Holdings 4Q Net $12.1M >MCFT
- MasterCraft Boat Holdings 4Q Sales $154.1M >MCFT
- MasterCraft Boat Holdings 4Q Adj EPS 50c >MCFT
- Kalaris Therapeutics 3Q Loss/Shr 46c >KLRS
- Ambiq Micro 3Q Sales $38.1M >AMBQ
- Ambiq Micro 3Q Loss/Shr 29c >AMBQ
- Xilio Therapeutics 3Q Loss $5.95M >XLO
- Xilio Therapeutics 3Q Loss/Shr 30c >XLO
- Exagen 3Q Loss/Shr 25c >XGN
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Humacyte 3Q Research and Development Expenses $14.1M >HUMA
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- FactSet Research Backs FY27 View of Adj EPS $19.25-Adj EPS $19.65 >FDS
- FactSet Research Backs FY27 View of Rev $2.6B-$2.635B >FDS
- Olema Pharmaceuticals 3Q Loss/Shr 73c >OLMA
- Legend Biotech 3Q EPS 13c >LEGN
- Alliance Laundry Holdings Sees 2026 Rev Up 6%-7% >ALH
- Ethan Allen: Stefanie Tsen Ward, Anna Brockway, Lindsay O'Reilly and Adam Treanor Appointed to Bd >ETD
- Terrestrial Energy Ended 3Q With $276.3M in Cash and Cash Equivalents and Short-term Investments >IMSR
- WhiteFiber 3Q Loss/Shr $2.44 >WYFI
- Sionna Therapeutics 3Q Loss/Shr 72c >SION
- Sionna Therapeutics 3Q Loss $32.4M >SION
- WhiteFiber 3Q Loss $101.4M >WYFI
- Vecima Networks Declares Quarterly Dividend of CA$0.055
- B. Riley Adjusts Price Target on Lincoln Educational Services to $50 From $52, Maintains Buy Rating
- Deutsche Bank Adjusts Onto Innovation Price Target to $240 From $330, Maintains Buy Rating
- --B. Riley Adjusts Price Target on Clarus to $6 From $4.50, Keeps Buy Rating
- --B. Riley Adjusts Price Target on Eton Pharmaceuticals to $81 From $70, Keeps Buy Rating
- PyroGenesis Secures Third Titanium Powder Contract with US Applied Research Lab
- General Mills Shuffles Business Segments to Form New Operating Model
- -- Earnings Flash (FTT.TO) Finning International Reports Q3 Revenue CA$3.04B, vs. FactSet Est of CA$2.97B
- -- Earnings Flash (FTT.TO) Finning International Posts Q3 Adjusted EPS CA$1.20 vs. FactSet Est of CA$1.25
- US Equity Futures Mixed Pre-Bell as Fed Governor Christopher Waller Leans Towards Rate Hike in December
- Cullinan Therapeutics Q3 Net Loss Narrows, Beats Estimates
- Ethan Allen Names Stefanie Tsen Ward Interim CEO, Appoints Four Directors
- RBC Cuts Price Target on Vivid Seats to $4 From $9, Keeps Sector Perform Rating
- Quarterhill Q3 Loss Widens, Revenue Rises
- Top Premarket Decliners
- -- Earnings Flash (ADCO.TO) Adcore Inc. Reports Q3 Revenue CA$5.8M
- -- Earnings Flash (NOW.V) NowVertical Group Reports Q3 Revenue $10.1M
- Immatics Q3 Net Loss Widens, Revenue Increases
- Blackstone to Acquire 15.57% Stake in IIFL Finance
